The role of patient-based treatment planning in peptide receptor radionuclide therapy

被引:0
作者
Deni Hardiansyah
Christian Maass
Ali Asgar Attarwala
Berthold Müller
Peter Kletting
Felix M. Mottaghy
Gerhard Glatting
机构
[1] Heidelberg University,Medical Radiation Physics/Radiation Protection, Universitätsmedizin Mannheim, Medical Faculty Mannheim
[2] Universitätsmedizin Mannheim,Department of Radiation Oncology
[3] Medical Faculty Mannheim,Klinik für Nuklearmedizin
[4] Heidelberg University,Klinik für Nuklearmedizin
[5] University Hospital,Department of Nuclear Medicine
[6] RWTH Aachen University,undefined
[7] Universität Ulm,undefined
[8] Maastricht University Medical Center (MUMC+),undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2016年 / 43卷
关键词
PRRT; PBPK modeling; Treatment planning; PET;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:871 / 880
页数:9
相关论文
共 228 条
  • [41] Bunjes D(2011)Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT Eur J Nucl Med Mol Imaging 38 1270-80
  • [42] Reske SN(2010)PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma Eur J Nucl Med Mol Imaging 37 1238-50
  • [43] Glatting G(2000)Patient-specific dosimetry in radionuclide therapy Eur J Endocrinol 143 S9-14
  • [44] Thomas SR(2001)Experimental facts supporting a red marrow uptake due to radiometal transchelation in Minerva Endocrinol 26 111-7
  • [45] Marincek N(2009)Y-DOTATOC therapy and relationship to the decrease of platelet counts Eur J Nucl Med Mol Imaging 36 1138-46
  • [46] Jorg AC(undefined)EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry undefined undefined undefined-undefined
  • [47] Brunner P(undefined)Somatostatin receptors in the haematopoietic system undefined undefined undefined-undefined
  • [48] Schindler C(undefined)Immunity and somatostatin receptors undefined undefined undefined-undefined
  • [49] Koller MT(undefined)Bone marrow dosimetry in peptide receptor radionuclide therapy with [ undefined undefined undefined-undefined
  • [50] Rochlitz C(undefined)Lu-DOTA(0), Tyr(3)]octreotate undefined undefined undefined-undefined